220 related articles for article (PubMed ID: 16978931)
21. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
Pichini S; Pujadas M; Marchei E; Pellegrini M; Fiz J; Pacifici R; Zuccaro P; Farré M; de la Torre R
J Pharm Biomed Anal; 2008 Jun; 47(2):335-42. PubMed ID: 18262381
[TBL] [Abstract][Full Text] [Related]
22. Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Ewald AH; Fritschi G; Maurer HH
J Mass Spectrom; 2006 Sep; 41(9):1140-8. PubMed ID: 16810708
[TBL] [Abstract][Full Text] [Related]
23. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Sauer C; Peters FT; Haas C; Meyer MR; Fritschi G; Maurer HH
J Mass Spectrom; 2009 Jun; 44(6):952-64. PubMed ID: 19241365
[TBL] [Abstract][Full Text] [Related]
24. Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection.
Tsai CC; Liu JT; Shu YR; Chan PH; Lin CH
J Chromatogr A; 2006 Jan; 1101(1-2):319-23. PubMed ID: 16325192
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry.
Ewald AH; Ehlers D; Maurer HH
Anal Bioanal Chem; 2008 Apr; 390(7):1837-42. PubMed ID: 18259731
[TBL] [Abstract][Full Text] [Related]
26. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
Habrdova V; Peters FT; Theobald DS; Maurer HH
J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
[TBL] [Abstract][Full Text] [Related]
27. Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.
Carmo H; Hengstler JG; de Boer D; Ringel M; Remião F; Carvalho F; Fernandes E; dos Reys LA; Oesch F; de Lourdes Bastos M
Toxicology; 2005 Jan; 206(1):75-89. PubMed ID: 15590110
[TBL] [Abstract][Full Text] [Related]
28. Analysis of 4-bromo-2,5-dimethoxyphenethylamine abuser's urine: identification and quantitation of urinary metabolites.
Kanamori T; Nagasawa K; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
J Forensic Sci; 2013 Jan; 58(1):279-87. PubMed ID: 23066942
[TBL] [Abstract][Full Text] [Related]
29. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
[TBL] [Abstract][Full Text] [Related]
30. Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone.
Staack RF; Maurer HH
J Anal Toxicol; 2003; 27(8):560-8. PubMed ID: 14670134
[TBL] [Abstract][Full Text] [Related]
31. Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.
Staack RF; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):333-42. PubMed ID: 14643514
[TBL] [Abstract][Full Text] [Related]
32. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.
Meyer MR; Wilhelm J; Peters FT; Maurer HH
Anal Bioanal Chem; 2010 Jun; 397(3):1225-33. PubMed ID: 20333362
[TBL] [Abstract][Full Text] [Related]
33. Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry.
Staack RF; Fritschi G; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 773(1):35-46. PubMed ID: 12015268
[TBL] [Abstract][Full Text] [Related]
34. Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n).
Wink CS; Meyer MR; Braun T; Turcant A; Maurer HH
Anal Bioanal Chem; 2015 Jan; 407(3):831-43. PubMed ID: 25120185
[TBL] [Abstract][Full Text] [Related]
35. Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.
Meyer MR; Schmitt S; Maurer HH
J Mass Spectrom; 2013 Feb; 48(2):243-9. PubMed ID: 23378097
[TBL] [Abstract][Full Text] [Related]
36. New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry.
Staack RF; Fehn J; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(1):27-41. PubMed ID: 12726841
[TBL] [Abstract][Full Text] [Related]
37. A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes.
Kanamori T; Tsujikawa K; Ohmae Y; Iwata YT; Inoue H; Kishi T; Nakahama T; Inouye Y
Forensic Sci Int; 2005 Mar; 148(2-3):131-7. PubMed ID: 15639607
[TBL] [Abstract][Full Text] [Related]
38. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
[TBL] [Abstract][Full Text] [Related]
39. Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B).
Power JD; Kavanagh P; O'Brien J; Barry M; Twamley B; Talbot B; Dowling G; Brandt SD
Drug Test Anal; 2015 Jun; 7(6):512-8. PubMed ID: 25078895
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and identification of urinary metabolites of 4-iodo-2,5-dimethoxyphenethylamine.
Kanamori T; Kuwayama K; Tsujikawa K; Miyaguchi H; Iwata YT; Inoue H
J Forensic Sci; 2011 Sep; 56(5):1319-23. PubMed ID: 21595694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
